Healthcare >> CEO Interviews >> July 2, 2007

George B. Schwartz – Dermtech International

TWST: May we start with a brief overview of your company.

Mr. Schwartz: The company is developing molecular diagnostic assays that can

employ our patented EGIR technology. "EGIR" stands for